Clinical, Pathological, and Molecular Characteristics of Diffuse Spinal Cord Gliomas

Abstract Diffuse spinal cord gliomas (SCGs) are rare tumors associated with a high morbidity and mortality that affect both pediatric and adult populations. In this retrospective study, we sought to characterize the clinical, pathological, and molecular features of diffuse SCG in 22 patients with hi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neuropathology and experimental neurology 2022-10, Vol.81 (11), p.865-872
Hauptverfasser: Garcia, Mekka R, Feng, Yang, Vasudevaraja, Varshini, Galbraith, Kristyn, Serrano, Jonathan, Thomas, Cheddhi, Radmanesh, Alireza, Hidalgo, Eveline T, Harter, David H, Allen, Jeffrey C, Gardner, Sharon L, Osorio, Diana S, William, Christopher M, Zagzag, David, Boué, Daniel R, Snuderl, Matija
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 872
container_issue 11
container_start_page 865
container_title Journal of neuropathology and experimental neurology
container_volume 81
creator Garcia, Mekka R
Feng, Yang
Vasudevaraja, Varshini
Galbraith, Kristyn
Serrano, Jonathan
Thomas, Cheddhi
Radmanesh, Alireza
Hidalgo, Eveline T
Harter, David H
Allen, Jeffrey C
Gardner, Sharon L
Osorio, Diana S
William, Christopher M
Zagzag, David
Boué, Daniel R
Snuderl, Matija
description Abstract Diffuse spinal cord gliomas (SCGs) are rare tumors associated with a high morbidity and mortality that affect both pediatric and adult populations. In this retrospective study, we sought to characterize the clinical, pathological, and molecular features of diffuse SCG in 22 patients with histological and molecular analyses. The median age of our cohort was 23.64 years (range 1–82) and the overall median survival was 397 days. K27M mutation was significantly more prevalent in males compared to females. Gross total resection and chemotherapy were associated with improved survival, compared to biopsy and no chemotherapy. While there was no association between tumor grade, K27M status (p = 0.366) or radiation (p = 0.772), and survival, males showed a trend toward shorter survival. K27M mutant tumors showed increased chromosomal instability and a distinct DNA methylation signature.
doi_str_mv 10.1093/jnen/nlac075
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2705752238</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/jnen/nlac075</oup_id><sourcerecordid>2823855254</sourcerecordid><originalsourceid>FETCH-LOGICAL-c323t-ad2a907b9cc3e2a38ed066b33369b7afe36140b9555147cb389fc5cd79cb5a023</originalsourceid><addsrcrecordid>eNp90EFLwzAUwPEgCs7pzQ8Q8KCH1b0mTdscpeoUJgrOc3lNU5eRNTVpD357O-rJg6fHgx-Px5-QyxhuY5B8uWt1u2wtKsjEEZnFQiRRKrL8mMwAGIs4pPKUnIWwAwAJMpmRTWFNaxTaBX3Dfuus-5w2bGv64qxWg0VPiy16VL32JvRGBeoaem-aZgiavnemRUsL52u6ssbtMZyTkwZt0Be_c04-Hh82xVO0fl09F3frSHHG-whrhhKySirFNUOe6xrStOKcp7LKsNE8jROopBAiTjJV8Vw2Sqg6k6oSCIzPyc10t_Pua9ChL_cmKG0tttoNoWQZiEwwxvORXv2hOzf48fFR5SMQgolkVItJKe9C8LopO2_26L_LGMpD4vKQuPxNPPLribuh-1_-ADMVfSQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2823855254</pqid></control><display><type>article</type><title>Clinical, Pathological, and Molecular Characteristics of Diffuse Spinal Cord Gliomas</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Garcia, Mekka R ; Feng, Yang ; Vasudevaraja, Varshini ; Galbraith, Kristyn ; Serrano, Jonathan ; Thomas, Cheddhi ; Radmanesh, Alireza ; Hidalgo, Eveline T ; Harter, David H ; Allen, Jeffrey C ; Gardner, Sharon L ; Osorio, Diana S ; William, Christopher M ; Zagzag, David ; Boué, Daniel R ; Snuderl, Matija</creator><creatorcontrib>Garcia, Mekka R ; Feng, Yang ; Vasudevaraja, Varshini ; Galbraith, Kristyn ; Serrano, Jonathan ; Thomas, Cheddhi ; Radmanesh, Alireza ; Hidalgo, Eveline T ; Harter, David H ; Allen, Jeffrey C ; Gardner, Sharon L ; Osorio, Diana S ; William, Christopher M ; Zagzag, David ; Boué, Daniel R ; Snuderl, Matija</creatorcontrib><description>Abstract Diffuse spinal cord gliomas (SCGs) are rare tumors associated with a high morbidity and mortality that affect both pediatric and adult populations. In this retrospective study, we sought to characterize the clinical, pathological, and molecular features of diffuse SCG in 22 patients with histological and molecular analyses. The median age of our cohort was 23.64 years (range 1–82) and the overall median survival was 397 days. K27M mutation was significantly more prevalent in males compared to females. Gross total resection and chemotherapy were associated with improved survival, compared to biopsy and no chemotherapy. While there was no association between tumor grade, K27M status (p = 0.366) or radiation (p = 0.772), and survival, males showed a trend toward shorter survival. K27M mutant tumors showed increased chromosomal instability and a distinct DNA methylation signature.</description><identifier>ISSN: 0022-3069</identifier><identifier>EISSN: 1554-6578</identifier><identifier>DOI: 10.1093/jnen/nlac075</identifier><language>eng</language><publisher>Cary: Oxford University Press</publisher><subject>Adults ; Biopsy ; Brain cancer ; Chemotherapy ; DNA methylation ; Genetic testing ; Genomes ; Glioma ; Histology ; Hospitals ; Laboratories ; Medical prognosis ; Mutation ; Pathology ; Pediatrics ; Radiation ; Spinal cord ; Surgery ; Tumors</subject><ispartof>Journal of neuropathology and experimental neurology, 2022-10, Vol.81 (11), p.865-872</ispartof><rights>The Author(s) 2022. Published by Oxford University Press on behalf of American Association of Neuropathologists, Inc. All rights reserved. For permissions, please email: journals.permissions@oup.com 2022</rights><rights>The Author(s) 2022. Published by Oxford University Press on behalf of American Association of Neuropathologists, Inc. All rights reserved. For permissions, please email: journals.permissions@oup.com</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c323t-ad2a907b9cc3e2a38ed066b33369b7afe36140b9555147cb389fc5cd79cb5a023</cites><orcidid>0000-0003-0752-0917</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1583,27923,27924</link.rule.ids></links><search><creatorcontrib>Garcia, Mekka R</creatorcontrib><creatorcontrib>Feng, Yang</creatorcontrib><creatorcontrib>Vasudevaraja, Varshini</creatorcontrib><creatorcontrib>Galbraith, Kristyn</creatorcontrib><creatorcontrib>Serrano, Jonathan</creatorcontrib><creatorcontrib>Thomas, Cheddhi</creatorcontrib><creatorcontrib>Radmanesh, Alireza</creatorcontrib><creatorcontrib>Hidalgo, Eveline T</creatorcontrib><creatorcontrib>Harter, David H</creatorcontrib><creatorcontrib>Allen, Jeffrey C</creatorcontrib><creatorcontrib>Gardner, Sharon L</creatorcontrib><creatorcontrib>Osorio, Diana S</creatorcontrib><creatorcontrib>William, Christopher M</creatorcontrib><creatorcontrib>Zagzag, David</creatorcontrib><creatorcontrib>Boué, Daniel R</creatorcontrib><creatorcontrib>Snuderl, Matija</creatorcontrib><title>Clinical, Pathological, and Molecular Characteristics of Diffuse Spinal Cord Gliomas</title><title>Journal of neuropathology and experimental neurology</title><description>Abstract Diffuse spinal cord gliomas (SCGs) are rare tumors associated with a high morbidity and mortality that affect both pediatric and adult populations. In this retrospective study, we sought to characterize the clinical, pathological, and molecular features of diffuse SCG in 22 patients with histological and molecular analyses. The median age of our cohort was 23.64 years (range 1–82) and the overall median survival was 397 days. K27M mutation was significantly more prevalent in males compared to females. Gross total resection and chemotherapy were associated with improved survival, compared to biopsy and no chemotherapy. While there was no association between tumor grade, K27M status (p = 0.366) or radiation (p = 0.772), and survival, males showed a trend toward shorter survival. K27M mutant tumors showed increased chromosomal instability and a distinct DNA methylation signature.</description><subject>Adults</subject><subject>Biopsy</subject><subject>Brain cancer</subject><subject>Chemotherapy</subject><subject>DNA methylation</subject><subject>Genetic testing</subject><subject>Genomes</subject><subject>Glioma</subject><subject>Histology</subject><subject>Hospitals</subject><subject>Laboratories</subject><subject>Medical prognosis</subject><subject>Mutation</subject><subject>Pathology</subject><subject>Pediatrics</subject><subject>Radiation</subject><subject>Spinal cord</subject><subject>Surgery</subject><subject>Tumors</subject><issn>0022-3069</issn><issn>1554-6578</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp90EFLwzAUwPEgCs7pzQ8Q8KCH1b0mTdscpeoUJgrOc3lNU5eRNTVpD357O-rJg6fHgx-Px5-QyxhuY5B8uWt1u2wtKsjEEZnFQiRRKrL8mMwAGIs4pPKUnIWwAwAJMpmRTWFNaxTaBX3Dfuus-5w2bGv64qxWg0VPiy16VL32JvRGBeoaem-aZgiavnemRUsL52u6ssbtMZyTkwZt0Be_c04-Hh82xVO0fl09F3frSHHG-whrhhKySirFNUOe6xrStOKcp7LKsNE8jROopBAiTjJV8Vw2Sqg6k6oSCIzPyc10t_Pua9ChL_cmKG0tttoNoWQZiEwwxvORXv2hOzf48fFR5SMQgolkVItJKe9C8LopO2_26L_LGMpD4vKQuPxNPPLribuh-1_-ADMVfSQ</recordid><startdate>20221018</startdate><enddate>20221018</enddate><creator>Garcia, Mekka R</creator><creator>Feng, Yang</creator><creator>Vasudevaraja, Varshini</creator><creator>Galbraith, Kristyn</creator><creator>Serrano, Jonathan</creator><creator>Thomas, Cheddhi</creator><creator>Radmanesh, Alireza</creator><creator>Hidalgo, Eveline T</creator><creator>Harter, David H</creator><creator>Allen, Jeffrey C</creator><creator>Gardner, Sharon L</creator><creator>Osorio, Diana S</creator><creator>William, Christopher M</creator><creator>Zagzag, David</creator><creator>Boué, Daniel R</creator><creator>Snuderl, Matija</creator><general>Oxford University Press</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0752-0917</orcidid></search><sort><creationdate>20221018</creationdate><title>Clinical, Pathological, and Molecular Characteristics of Diffuse Spinal Cord Gliomas</title><author>Garcia, Mekka R ; Feng, Yang ; Vasudevaraja, Varshini ; Galbraith, Kristyn ; Serrano, Jonathan ; Thomas, Cheddhi ; Radmanesh, Alireza ; Hidalgo, Eveline T ; Harter, David H ; Allen, Jeffrey C ; Gardner, Sharon L ; Osorio, Diana S ; William, Christopher M ; Zagzag, David ; Boué, Daniel R ; Snuderl, Matija</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c323t-ad2a907b9cc3e2a38ed066b33369b7afe36140b9555147cb389fc5cd79cb5a023</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adults</topic><topic>Biopsy</topic><topic>Brain cancer</topic><topic>Chemotherapy</topic><topic>DNA methylation</topic><topic>Genetic testing</topic><topic>Genomes</topic><topic>Glioma</topic><topic>Histology</topic><topic>Hospitals</topic><topic>Laboratories</topic><topic>Medical prognosis</topic><topic>Mutation</topic><topic>Pathology</topic><topic>Pediatrics</topic><topic>Radiation</topic><topic>Spinal cord</topic><topic>Surgery</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Garcia, Mekka R</creatorcontrib><creatorcontrib>Feng, Yang</creatorcontrib><creatorcontrib>Vasudevaraja, Varshini</creatorcontrib><creatorcontrib>Galbraith, Kristyn</creatorcontrib><creatorcontrib>Serrano, Jonathan</creatorcontrib><creatorcontrib>Thomas, Cheddhi</creatorcontrib><creatorcontrib>Radmanesh, Alireza</creatorcontrib><creatorcontrib>Hidalgo, Eveline T</creatorcontrib><creatorcontrib>Harter, David H</creatorcontrib><creatorcontrib>Allen, Jeffrey C</creatorcontrib><creatorcontrib>Gardner, Sharon L</creatorcontrib><creatorcontrib>Osorio, Diana S</creatorcontrib><creatorcontrib>William, Christopher M</creatorcontrib><creatorcontrib>Zagzag, David</creatorcontrib><creatorcontrib>Boué, Daniel R</creatorcontrib><creatorcontrib>Snuderl, Matija</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of neuropathology and experimental neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Garcia, Mekka R</au><au>Feng, Yang</au><au>Vasudevaraja, Varshini</au><au>Galbraith, Kristyn</au><au>Serrano, Jonathan</au><au>Thomas, Cheddhi</au><au>Radmanesh, Alireza</au><au>Hidalgo, Eveline T</au><au>Harter, David H</au><au>Allen, Jeffrey C</au><au>Gardner, Sharon L</au><au>Osorio, Diana S</au><au>William, Christopher M</au><au>Zagzag, David</au><au>Boué, Daniel R</au><au>Snuderl, Matija</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical, Pathological, and Molecular Characteristics of Diffuse Spinal Cord Gliomas</atitle><jtitle>Journal of neuropathology and experimental neurology</jtitle><date>2022-10-18</date><risdate>2022</risdate><volume>81</volume><issue>11</issue><spage>865</spage><epage>872</epage><pages>865-872</pages><issn>0022-3069</issn><eissn>1554-6578</eissn><abstract>Abstract Diffuse spinal cord gliomas (SCGs) are rare tumors associated with a high morbidity and mortality that affect both pediatric and adult populations. In this retrospective study, we sought to characterize the clinical, pathological, and molecular features of diffuse SCG in 22 patients with histological and molecular analyses. The median age of our cohort was 23.64 years (range 1–82) and the overall median survival was 397 days. K27M mutation was significantly more prevalent in males compared to females. Gross total resection and chemotherapy were associated with improved survival, compared to biopsy and no chemotherapy. While there was no association between tumor grade, K27M status (p = 0.366) or radiation (p = 0.772), and survival, males showed a trend toward shorter survival. K27M mutant tumors showed increased chromosomal instability and a distinct DNA methylation signature.</abstract><cop>Cary</cop><pub>Oxford University Press</pub><doi>10.1093/jnen/nlac075</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-0752-0917</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-3069
ispartof Journal of neuropathology and experimental neurology, 2022-10, Vol.81 (11), p.865-872
issn 0022-3069
1554-6578
language eng
recordid cdi_proquest_miscellaneous_2705752238
source Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Adults
Biopsy
Brain cancer
Chemotherapy
DNA methylation
Genetic testing
Genomes
Glioma
Histology
Hospitals
Laboratories
Medical prognosis
Mutation
Pathology
Pediatrics
Radiation
Spinal cord
Surgery
Tumors
title Clinical, Pathological, and Molecular Characteristics of Diffuse Spinal Cord Gliomas
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T11%3A07%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical,%20Pathological,%20and%20Molecular%20Characteristics%20of%20Diffuse%20Spinal%20Cord%20Gliomas&rft.jtitle=Journal%20of%20neuropathology%20and%20experimental%20neurology&rft.au=Garcia,%20Mekka%20R&rft.date=2022-10-18&rft.volume=81&rft.issue=11&rft.spage=865&rft.epage=872&rft.pages=865-872&rft.issn=0022-3069&rft.eissn=1554-6578&rft_id=info:doi/10.1093/jnen/nlac075&rft_dat=%3Cproquest_cross%3E2823855254%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2823855254&rft_id=info:pmid/&rft_oup_id=10.1093/jnen/nlac075&rfr_iscdi=true